Raymond James has set a $205 price target for PSX, as the company's refining margins have nearly doubled.

AeroVironment's stock has received an upgrade from Raymond James, following a reset in its valuation. This positive assessment reflects new market perspectives on the company's financial standing.

Raymond James analysts express confidence in economic resilience despite ongoing conflicts and suggest buying two specific beaten-down stocks.

Raymond James has upgraded Oscar Health, Inc. (OSCR), while UBS has lowered its price target for the company, reflecting differing analyst perspectives.

Raymond James has lowered its price target for Viking Therapeutics, Inc. (VKTX), despite an optimistic outlook on the company's clinical initiatives.

TD Cowen has reiterated its 'Hold' rating on Raymond James Financial (RJF) shares.

UFP Technologies is scheduled to present and host one-on-one investor meetings at the Raymond James 47th Annual Institutional Investors Conference.

Raymond James has expressed a bullish outlook on CBRE Group, Inc. (CBRE), indicating confidence in the company's future performance.

Raymond James has adjusted its price target for Mobileye Global Inc. (MBLY) to $16, citing the company's potential for earnings leverage.

Raymond James has upgraded Chewy's stock to an 'Outperform' rating, projecting a 16% increase in shares due to an anticipated stronger consumer market.

Raymond James has downgraded Baytex Energy Corp. (BTE) to 'Market Perform' following a significant 40% rally in its share price.

An analysis investigates if Raymond James Financial stock (RJF) is underperforming when compared to the overall financial sector.

The CEO of Royal Gold, Inc. highlighted the company's strong financial results during a presentation at the Raymond James Conference, underscoring its performance.

Sumitomo Mitsui Trust is reportedly forming an alliance with Raymond James in the United States, leveraging Raymond James' extensive network of small and medium-sized business clients and wealth management customers.

Raymond James has reportedly cut its target for Brown and Brown (BRO) shares by $8.

Concurrent has reportedly recruited a $300 million father-daughter team from Raymond James.

Rapid7 announced its attendance at the Raymond James 47th Annual Institutional Investors Conference.

Genuine Parts Company has been upgraded by Raymond James, citing an attractive risk-reward profile for investors.

Raymond James Financial has declared a dividend of $0.54 per share.

Raymond James has increased its price target for NVIDIA (NVDA) stock, signaling a positive outlook for the technology company.

Raymond James has chosen an internal candidate to lead its independent contractor division, signaling a strategic move in its leadership structure.

Akamai Technologies is gaining attention after Raymond James increased its price target for the company, signaling a positive outlook.

Raymond James has expressed increased confidence in WEX's (WEX) growth trajectory for 2026, following an assessment of the company's prospects.

C.H. Robinson Worldwide touted its 'Lean AI' gains at the Raymond James Conference, even as freight demand remains subdued.

Raymond James believes a cross-selling ban could be beneficial in attracting new advisors, according to a recent report.

ANI Pharmaceuticals outlined its strategic vision at the Raymond James Conference, aiming for over $1 billion in sales by 2026, with a key focus on expanding its presence in the rare disease market.

Microchip Technology is scheduled to deliver a presentation at the upcoming Raymond James Institutional Investors Conference.

Raymond James has upgraded Lumexa Imaging Holdings, Inc. (LMRI) to a Strong Buy rating, maintaining an unchanged price target of $23.

Raymond James has double upgraded Genuine Parts Company, anticipating a 25% rally in shares ahead of a planned business separation.

Raymond James views Chewy as an attractive investment opportunity, citing intact growth drivers for the online pet retailer.

Several financial institutions, including Stifel, Scotiabank, and Jefferies, have issued updated price targets and ratings for various companies. These reports reflect analysts' current outlooks on stock performance and investment recommendations.